Detalhe da pesquisa
1.
Determining the optimal pharmacokinetic modelling and simplified quantification method of [18F]AlF-P16-093 for patients with primary prostate cancer (PPCa).
Eur J Nucl Med Mol Imaging
; 2024 Jan 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38285206
2.
First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients.
Eur J Nucl Med Mol Imaging
; 51(6): 1753-1762, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38212531
3.
Comparison of novel PSMA-targeting [177Lu]Lu-P17-087 with its albumin binding derivative [177Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study.
Eur J Nucl Med Mol Imaging
; 2024 Apr 25.
Artigo
Inglês
| MEDLINE | ID: mdl-38658392
4.
Head-to-head comparison of [68Ga]Ga-P16-093 and 2-[18F]FDG PET/CT in patients with clear cell renal cell carcinoma: a pilot study.
Eur J Nucl Med Mol Imaging
; 50(5): 1499-1509, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36600099
5.
A prospective head-to-head comparison of [68Ga]Ga-P16-093 and [68Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer.
Eur J Nucl Med Mol Imaging
; 50(10): 3126-3136, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37233785
6.
[68Ga]Ga-HBED-CC-FAPI Derivatives with Improved Radiolabeling and Specific Tumor Uptake.
Mol Pharm
; 20(4): 2159-2169, 2023 04 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36942924
7.
Head-to-head comparison of [68 Ga]Ga-P16-093 and [68 Ga]Ga-PSMA-617 in dynamic PET/CT evaluation of the same group of recurrent prostate cancer patients.
Eur J Nucl Med Mol Imaging
; 49(3): 1052-1062, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34557930
8.
In vivo and in vitro binding of [125 I]I-R-(+)-TISCH: A dopamine D1 receptor ligand for studying pancreatic ß-cell mass.
J Labelled Comp Radiopharm
; 65(14): 354-360, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36261868
9.
Radiolabeling Optimization and Preclinical Evaluation of the New PSMA Imaging Agent [18F]AlF-P16-093.
Bioconjug Chem
; 32(5): 1017-1026, 2021 05 19.
Artigo
Inglês
| MEDLINE | ID: mdl-33872489
10.
Dynamic PET/CT imaging of 18F-(2S, 4R)4-fluoroglutamine in healthy volunteers and oncological patients.
Eur J Nucl Med Mol Imaging
; 47(10): 2280-2292, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32166510
11.
Synthesis and Evaluation of 68Ga- and 177Lu-Labeled (R)- vs (S)-DOTAGA Prostate-Specific Membrane Antigen-Targeting Derivatives.
Mol Pharm
; 17(12): 4589-4602, 2020 12 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33108189
12.
A New [68Ga]Ga-HBED-CC-Bisphosphonate as a Bone Imaging Agent.
Mol Pharm
; 17(5): 1674-1684, 2020 05 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32251600
13.
Synthesis and evaluation of novel radioiodinated PSMA targeting ligands for potential radiotherapy of prostate cancer.
Bioorg Med Chem
; 28(5): 115319, 2020 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32001090
14.
An improved preparation of [18 F]AV-45 by simplified solid-phase extraction purification.
J Labelled Comp Radiopharm
; 63(3): 108-118, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31697847
15.
In Vivo Ester Hydrolysis as a New Approach in Development of Positron Emission Tomography Tracers for Imaging Hypoxia.
Mol Pharm
; 16(3): 1156-1166, 2019 03 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30676751
16.
Synthesis and preliminary evaluation of a novel glutamine derivative: (2S,4S)4-[18F]FEBGln.
Bioorg Med Chem Lett
; 29(9): 1047-1050, 2019 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30871772
17.
Initial experience in synthesis of (2S,4R)-4-[18 F]fluoroglutamine for clinical application.
J Labelled Comp Radiopharm
; 62(5): 209-214, 2019 05 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30861162
18.
In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of 18F-(2S,4R)-4-Fluoroglutamine.
Radiology
; 287(2): 667-675, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29388903
19.
PET Imaging of 18F-(2 S,4 R)4-Fluoroglutamine Accumulation in Breast Cancer: From Xenografts to Patients.
Mol Pharm
; 15(8): 3448-3455, 2018 08 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29985631
20.
Deuterium-substituted 2-(2'-((dimethylamino)methyl)-4'-[18 F](fluoropropoxy)phenylthio)benzenamine as a serotonin transporter imaging agent.
J Labelled Comp Radiopharm
; 61(8): 576-585, 2018 06 30.
Artigo
Inglês
| MEDLINE | ID: mdl-29644713